Valued at $250.0M at its early-stage round, Dec 2025. Nothing has traded since.
- ·Watch Ambros Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Ambros Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Early Stage VC (Series A) | $154.0M | ▮ | ▮ |
Membership and data by Private Market View
Ambros Therapeutics valuation
Ambros Therapeutics was valued at $250 million at its early-stage round in Dec 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Ambros Therapeutics raised?
Ambros Therapeutics has raised $154 million across 1 recorded round since 2025. The largest was a $154 million Series A in Dec 2025.
Comparable companies
Comparable biotechnology names by valuation on PrivateMarketView: Ansa Biotechnologies ($269 million), Gameto ($243 million) and Antheia ($240 million).
How Ambros Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ambros Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Ambros Therapeutics
- What is Ambros Therapeutics worth?
- Ambros Therapeutics is valued at $250.0M as of Oct 2026. Valued at $250.0M at its early-stage round, Dec 2025. Nothing has traded since.
- How much has Ambros Therapeutics raised?
- Ambros Therapeutics has raised $154.0M in total funding across 1 recorded rounds.
- When did Ambros Therapeutics last raise?
- Ambros Therapeutics last raised in Dec 2025 (Early Stage VC (Series A)), raising $154.0M.